ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 41st Annual J.P. Morgan Healthcare Conference
ZyVersa is a clinical stage biopharmaceutical company developing first-in-class product candidates to address significant unmet medical needs of patients with...
Source: prnewswire.com